The store will not work correctly when cookies are disabled.
1-Allyl-3-ethyl-5-(3-thiophen-2-yl-allylidene)-2-thioxodihydro-pyrimidine-4,6-dione
ID: ALA4173688
PubChem CID: 145950157
Max Phase: Preclinical
Molecular Formula: C16H16N2O2S2
Molecular Weight: 332.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCN1C(=O)/C(=C\C=C\c2cccs2)C(=O)N(CC)C1=S
Standard InChI: InChI=1S/C16H16N2O2S2/c1-3-10-18-15(20)13(14(19)17(4-2)16(18)21)9-5-7-12-8-6-11-22-12/h3,5-9,11H,1,4,10H2,2H3/b7-5+,13-9-
Standard InChI Key: FQOQQCYDJMHOLF-HUZLQASOSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
12.6099 -9.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6099 -10.5248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9021 -10.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1944 -10.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1944 -9.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9021 -9.2982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9021 -11.7555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4866 -9.2982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3218 -9.2982 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.4866 -10.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7747 -10.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0669 -10.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3591 -10.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6123 -10.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0647 -10.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4722 -9.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2740 -9.7121 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.3218 -10.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0296 -10.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9021 -8.4791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6099 -8.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6099 -7.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
12 13 1 0
4 10 2 0
18 19 1 0
2 18 1 0
20 21 1 0
21 22 2 0
6 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.45 | Molecular Weight (Monoisotopic): 332.0653 | AlogP: 2.85 | #Rotatable Bonds: 5 |
Polar Surface Area: 40.62 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.65 | CX LogD: 3.65 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.36 | Np Likeness Score: -1.59 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |